Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

237.33
Delayed Data
As of Mar 24
 +2.04 / +0.87%
Today’s Change
184.50
Today|||52-Week Range
281.28
+13.01%
Year-to-Date
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Mar 24 / Zacks.com - Paid Partner Content
Bidding for 4 'Keepers'
Mar 21 / TheStreet.com - Paid Partner Content
Teva Pharma Denies Rumors of Global Workforce Reduction
Mar 24 / Zacks.com - Paid Partner Content
Buying Allergan
Mar 21 / TheStreet.com - Paid Partner Content
All Eyes On Washington: US Futures Rise On Hope Healthcare Vote Will Pass
Mar 24 / Investing Channel - Paid Partner Content
Adding to Allergan
Mar 21 / TheStreet.com - Paid Partner Content
The Most Attractive Value Stock There Is?
Mar 23 / GuruFocus News - Paid Partner Content
North Tide Capital, Llc Buys Impax Laboratories, Allergan PLC, Accuray, Sells Communi...
Mar 20 / GuruFocus News - Paid Partner Content
The Good, the Bad and the Ugly (Early Afternoon Edition)
Mar 23 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: AstraZeneca's Lynparza Impresses in Study, Merck Drug Label Exp...
Mar 17 / Zacks.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 23 / GuruFocus News - Paid Partner Content
Allergan (AGN) and Editas Tie Up to Treat Eye Diseases
Mar 15 / Zacks.com - Paid Partner Content
AstraZeneca Stock Rising in '17: What's Working in its Favor?
Mar 23 / Zacks.com - Paid Partner Content
Paulson nurses losses as Ackman exits Valeant
Mar 15 / FT.com - Paid Partner Content
Adding to AGN Long
Mar 23 / TheStreet.com - Paid Partner Content
Here's Why Editas Medicine Gained as Much as 17.2% Today
Mar 14 / MotleyFool.com - Paid Partner Content
Allergan's Restasis Now Available in Multidose Bottle in U.S.
Mar 23 / Zacks.com - Paid Partner Content
Acorda's Four Ampyra Patents Upheld by PTAB, Shares Rise
Mar 13 / Zacks.com - Paid Partner Content
Companies Spend Less on Share Buybacks for Second Year in 2016
Mar 23 / GuruFocus News - Paid Partner Content
Aerie Resubmits Rhopressa NDA, Roclatan Gains Traction
Mar 13 / Zacks.com - Paid Partner Content
Corporate Share Repurchases Decline for 2nd Year in a Row
Mar 22 / GuruFocus News - Paid Partner Content
Synergy Pharmaceuticals: Approval, Now What?
Mar 13 / MotleyFool.com - Paid Partner Content
Saba Capital Management, L.P. Buys Allergan PLC, Alpine Total Dynamic Dividend Fund, ...
Mar 21 / GuruFocus News - Paid Partner Content
Trump's pledge on drug pricing squeezes pharma stocks
Mar 07 / FT.com - Paid Partner Content
David Tepper Takes Big Risks for Big Rewards
Mar 21 / GuruFocus News - Paid Partner Content
Hyena capitalism receives a swift kick from the Unilever giraffe
Feb 24 / FT.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content